1-2 of 2
Lone Friis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A randomized comparison of daunorubicin 90 mg/m 2 vs 60 mg/m 2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients

CME Clinical Trials & Observations
Alan K. Burnett, Nigel H. Russell, Robert K. Hills, Jonathan Kell, Jamie Cavenagh, Lars Kjeldsen, Mary-Frances McMullin, Paul Cahalin, Mike Dennis, Lone Friis, Ian F. Thomas, Don Milligan, Richard E. Clark
Journal: Blood
Blood (2015) 125 (25): 3878–3885.
https://doi.org/10.1182/blood-2015-01-623447
Published: 2015
Includes: Supplemental data
Journal Articles

Mutation in the Nucleophosmin Gene (NPM1) Is a Stable Marker for Minimal Residual Disease Monitoring in Acute Myeloid Leukemia Patients with Increased Sensitivity and Specificity Compared to Expression of the Wilms Tumor (WT1) Gene.

Thomas Kristensen, PhD, Birgitte Strange Preiss, MD, Lone Friis, MD, PhD, Michael B. Møller, MD, DMSc
Journal: Blood
Blood (2009) 114 (22): 1602.
https://doi.org/10.1182/blood.V114.22.1602.1602
Published: 2009